HIF-1α promotes the keloid development through the activation of TGF-β/Smad and TLR4/MyD88/NF-κB pathways

TNF-α inhibits SCF, ghrelin, and substance P expressions through the NF-κB pathway activation in interstitial cells of Cajal

(2018) Keyu Ren et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

TGF-β1 promotes Staphylococcus aureus adhesion to and invasion into bovine mammary fibroblasts via the ERK pathway

(2017) Shuang Zhao et al.   MICROBIAL PATHOGENESIS

Hypoxia-inducible factor-1α activates transforming growth factor-β1/Smad signaling and increases collagen deposition in dermal fibroblasts

(2017) Xu Mingyuan et al.   Oncotarget

Toll-Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Inflammatory Development of Polymyositis by Mediating Interferon-γ and Interleukin-17A in Humans and Experimental Autoimmune Myositis Mouse Model

(2017) Hongya Zhang et al.   Frontiers in Neurology

FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4

(2016) Qiang Zhang et al.   MOLECULAR CELL

NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma

(2015) Hui Wang et al.   Molecular Cancer

Clinical and epidemiological analysis of keloids in Chinese patients

(2014) Wen-sheng Lu et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

New Insights on Keloids, Hypertrophic Scars, and Striae

(2014) Sara Ud-Din et al.   DERMATOLOGIC CLINICS

Critical Role of Transforming Growth Factor Beta in Different Phases of Wound Healing

(2013) Mohammadreza Pakyari et al.   Advances in Wound Care

The effect of TLR4/7 on the TGF-β-induced Smad signal transduction pathway in human keloid

(2012) Jialiang Chen et al.   BURNS

Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors

(2012) Yan Xia et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers

(2012) C Freudlsperger et al.   ONCOGENE

Cancer Therapeutic Agents Targeting Hypoxia-Inducible Factor-1

(2011) R. Wang et al.   CURRENT MEDICINAL CHEMISTRY

Inhibiting scar formation in vitro and in vivo by adenovirus-mediated mutant Smad4: a preliminary report

(2011) Wei-Qiang Tan et al.   EXPERIMENTAL DERMATOLOGY

Standard guidelines of care: Keloids and hypertrophic scars

(2011) Somesh Gupta et al.   Indian Journal of Dermatology Venereology & Leprology

Oxygen in acute and chronic wound healing

(2010) S. Schreml et al.   BRITISH JOURNAL OF DERMATOLOGY

Regional differences in wound oxygenation during normal healing in an equine model of cutaneous fibroproliferative disorder

(2010) Christophe J. Celeste et al.   WOUND REPAIR AND REGENERATION

Reduced liver fibrosis in hypoxia-inducible factor-1α-deficient mice

(2009) Jeon-OK Moon et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The ERK signaling cascade-Views from different subcellular compartments

(2009) Zhong Yao et al.   BIOFACTORS

Hypertrophic Scars and Keloids—A Review of Their Pathophysiology, Risk Factors, and Therapeutic Management

(2009) Dolores Wolfram et al.   DERMATOLOGIC SURGERY

Toll-Like Receptor 4: A Novel Signaling Pathway During Renal Fibrogenesis

(2009) Matthew T. Campbell et al.   JOURNAL OF SURGICAL RESEARCH

Role of transforming growth factor-β superfamily signaling pathways in human disease

(2008) Kelly J. Gordon et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Regulation of gene expression by hypoxia: Integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element

(2008) Stefan Kaluz et al.   CLINICA CHIMICA ACTA